ONPH is exploring strategic partnerships and opportunities in oncology

Our Portfolio (Licences)

Nanosmart Pharmaceuticals  -  
NanoSmart's® platform technology  (US  Patent No: 7,799,327 and EU 1706145 B1)

Tulynode  -   

Tulynode's "patent pending" Autologous Cellular Immuno-therapy extracorporeal device

​

​

​

​

​

​

​

​

Licences